Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
NeoGenomics, Inc. (NEO) had Cost of Goods Sold of $90.77M for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
$156.24M |
|
$-27.06M |
|
|
Cost of Goods Sold |
$90.77M |
$65.47M |
|
$186.81M |
|
$-30.57M |
|
$2.89M |
|
$-27.68M |
|
$-27.68M |
|
$-27.06M |
|
$-27.06M |
|
$-27.06M |
|
$-27.06M |
|
$-30.57M |
|
$-11.57M |
|
126.11M |
|
126.11M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$573.90M |
|
$87.86M |
|
$1.07B |
|
$1.64B |
|
$76.71M |
|
$538.92M |
|
$640.22M |
|
$716.93M |
|
$923.41M |
|
$35.88M |
|
$923.41M |
|
127.44M |
|
| Cash Flow Statement Financials | |
$-25.91M |
|
$14.53M |
|
$0.82M |
|
$342.49M |
|
$331.91M |
|
$-10.57M |
|
$7.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.48 |
|
-- |
|
-- |
|
0.37 |
|
0.58 |
|
41.90% |
|
-19.56% |
|
-19.56% |
|
-- |
|
-17.72% |
|
-17.32% |
|
$-31.50M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
4.47 |
|
1.11 |
|
80.81 |
|
-2.93% |
|
-75.42% |
|
-1.65% |
|
-1.85% |
|
$7.25 |
|
$-0.25 |
|
$-0.21 |
|